Michel Guichardant Selected Research

Michel Guichardant Research Topics

Disease

5	Atherosclerosis 11/2018 - 04/2009
4	Inflammation (Inflammations) 12/2020 - 10/2012
4	Thrombosis (Thrombus) 11/2018 - 04/2009
3	Insulin Resistance 01/2018 - 02/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2013 - 02/2010
2	Stroke (Strokes) 01/2017 - 05/2011
2	Obesity 02/2013 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 02/2013 - 03/2009
1	Arthritis (Polyarthritis) 10/2022
1	Osteoarthritis 10/2022
1	Neuroinflammatory Diseases 08/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Ischemic Stroke 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 12/2016
1	Disease Progression 12/2016
1	Coronary Disease (Coronary Heart Disease) 04/2015
1	Metabolic Diseases (Metabolic Disease) 03/2015
1	Confusion (Bewilderment) 04/2014
1	Cognitive Dysfunction 02/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2011
1	Hyperglycemia 04/2010
1	Hyperoxia 07/2009
1	Hemolysis 07/2009
1	Hypoxia (Hypoxemia) 07/2009

Drug/Important Bio-Agent (IBA)

5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018 - 05/2011
4	oxidized low density lipoproteinIBA 04/2015 - 02/2010
4	AntioxidantsIBA 03/2015 - 02/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 07/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2010
3	Docosahexaenoic AcidsIBA 08/2017 - 05/2011
3	Phospholipids (Phosphatides)FDA LinkGeneric 08/2017 - 03/2009
2	LipidsIBA 10/2022 - 04/2015
2	Eicosapentaenoic AcidIBA 11/2018 - 01/2016
2	1- acetyl- 2- docosahexaenoyl- glycerophosphocholineIBA 08/2017 - 05/2011
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2015 - 02/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2020
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	4-hydroxy-2-hexenalIBA 01/2018
1	LipopolysaccharidesIBA 08/2017
1	Choline (Choline Chloride)IBA 08/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 08/2017
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2017
1	Apolipoproteins E (ApoE)IBA 12/2016
1	ApolipoproteinsIBA 12/2016
1	IsoprostanesIBA 04/2015
1	AcidsIBA 04/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2015
1	JNK Mitogen-Activated Protein KinasesIBA 03/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2015
1	Insulin (Novolin)FDA Link 03/2015
1	OzoneIBA 03/2015
1	pyrazolanthroneIBA 03/2015
1	4-phenylbutyric acid (Buphenyl)FDA Link 03/2015
1	10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA 04/2014
1	protectin D1IBA 04/2014
1	Peroxidase (Myeloperoxidase)IBA 01/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 02/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2013
1	Inositol (Myoinositol)IBA 02/2013
1	ProstaglandinsIBA 11/2012
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 05/2011
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2010
1	PPAR deltaIBA 04/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2009
1	Isoflurane FDA LinkGeneric 07/2009
1	Vitamin E FDA LinkGeneric 07/2009
1	Free RadicalsIBA 07/2009
1	Oxygen (Dioxygen)IBA 07/2009
1	CholesterolIBA 07/2009
1	Arachidonic Acid (Vitamin F)IBA 04/2009
1	VLDL LipoproteinsIBA 03/2009
1	HDL LipoproteinsIBA 03/2009

Therapy/Procedure

2	Intravenous Injections 01/2018 - 05/2011
1	Therapeutics 01/2017